1. "Hematologic Malignancies Service"
Formats
  1. Journal Article (349)
  2. Meeting Abstract (232)
  3. Review (11)
  4. Research Letter (5)
  5. Editorial (4)
  6. Book Section (2)
  7. Conference Paper (2)
  8. Correspondence (1)
  9. Guidelines (1)
Groups
  1. Hematologic Malignancies Service (607)
  2. Pediatrics, Department of (607)
  3. Center for Hematologic Malignancies (554)
  4. Pediatric Leukemia (455)
  5. GSK Faculty (220)
  6. Tow Center for Developmental Oncology (TCDO) (206)

More Groups

People
  1. Peter Steinherz (221)
  2. Neerav Shukla (159)
  3. Tanya Trippett (126)
  4. Alex Kentsis (103)
  5. Christopher Forlenza (49)
  6. Marc Ladanyi (44)

More People

Years
  1. 2025 (11)
  2. 2024 (27)
  3. 2023 (37)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (29)

More Years

Publications
  1. Blood (125)
  2. Journal of Clinical Oncology (61)
  3. Pediatric Blood and Cancer (57)
  4. Cancer Research (22)
  5. Cancer (18)
  6. Journal of Pediatric Hematology/Oncology (16)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. American Society of Clinical Oncology (69)
  3. Wiley Periodicals, Inc (57)
  4. American Association for Cancer Research (56)
  5. Nature Publishing Group (39)
  6. Elsevier Inc. (33)

More Publishers

Results (607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Blinatumomab in pediatric patients with relapsed/refractory (R/R) B-cell precursor acute lymphoblastic leukemia (Bcp-All): A phase 1/2 study
    Meeting Abstract

    Whitlock, J.; Von Stackelberg, A.; Handgretinger, R.; Locatelli, F.; Rizzari, C.; Trippett, T.; Borkhardt, A.; O'brien, M.; Rheingold, S.; Gore, L.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save
  • High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children
    Journal Article

    Kobos, R.; Shukla, N.; Renaud, T.; Prockop, S. E.; Boulad, F.; Steinherz, P. G.
    Journal of Pediatric Hematology/Oncology (2014)

    Fulltext@MSK | Save
  • Prolonged hypogammaglobulinemia in pediatric lymphoma patients after rituximab therapy
    Meeting Abstract

    Terry, W.; Shukla, N.; Renaud, T.; Kernan, N.; Chaudhuri, J.; Steinherz, P.; Kobos, R.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save
  • A recurrent point mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma
    Meeting Abstract

    Kohsaka, S.; Shukla, N.; Ameur, N.; Lim, D. ; Viale, A.; Socci, N.; Qin, L. X.; Sciot, R.; Bridge, J.; Singer, S.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
    Journal Article

    Kohsaka, S.; Shukla, N.; Ameur, N.; Ito, T.; Ng, C. K. Y.; Wang, L.; Lim, D. ; Marchetti, A.; Viale, A.; Pirun, M.; more...
    Nature Genetics (2014)

    Fulltext@MSK | Save
  • Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?
    Meeting Abstract

    Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Busulfan, melphalan, and thiotepa conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) of pediatric patients with acute leukemia and central nervous system (CNS) disease
    Meeting Abstract

    Forlenza, C. J.; Kobos, R.; Kernan, N. A.; Scaradavou, A.; Prockop, S. E.; Curran, K.; Shukla, N.; Steinherz, P. G.; O'reilly, R.; Boulad, F.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia
    Journal Article

    Shukla, N.; Kobos, R.; Renaud, T.; Steinherz, L. J.; Steinherz, P. G.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save
  • A phase I study of ridaforolimus (MK-8669) in pediatric patients with advanced solid tumors
    Meeting Abstract

    Pearson, A. D. J.; Federico, S. M.; Aerts, I.; Hargrave, D. R.; DuBois, S. G.; Iannone, R.; Geschwindt, R.; Wang, R. X.; Trippett, T. M.; Geoerger, B.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II trial of radiation and cetuximab followed by irinotecan/cetuximab for children with newly diagnosed diffuse pontine tumors and high-grade astrocytomas
    Meeting Abstract

    Macy, M.; Kieran, M. W.; Chi, S. N.; Cohen, K. J.; MacDonald, T.; Smith, A. A.; Etzl, M. M.; Narendran, A.; Gore, L.; DiRenzo, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save